China set to impose regulations on gene-editing following controversial trial with human embryos | WHAT REALLY HAPPENED

China set to impose regulations on gene-editing following controversial trial with human embryos

After global backlash involving the use of gene-editing tool CRISPR on human embryos, China will further tighten regulation on manipulating the human genome.

According to a report in Nature, a draft of new code in the country's civil law explicitly lists human genes and embryos as protected personal rights for the first time ever.

Lawyers interviewed by Nature say that the law would make any doctor or scientist engaging in the editing of the human genome liable for the outcome of their experiments.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA